Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model
文献类型:期刊论文
作者 | Schiapparelli, Paula1; Zhang, Pengcheng2,3,4![]() |
刊名 | JOURNAL OF CONTROLLED RELEASE
![]() |
出版日期 | 2020-03-10 |
卷号 | 319页码:311-321 |
关键词 | Prodrug Hydrogel Glioblastoma Local therapy Chemotherapy Camptothecin |
ISSN号 | 0168-3659 |
DOI | 10.1016/j.jconrel.2020.01.003 |
通讯作者 | Quinones-Hinojosa, Alfredo(quinones-hinojosa.alfredo@mayo.edu) ; Cui, Honggang(hcui6@jhu.edu) |
英文摘要 | Glioblastoma multiforme (GBM) is the most common and devastating type of primary brain cancer. Despite surgery and chemo/radiation therapy, recurrence often takes place and leads to patient death. We report here on the development of a camptothecin (CPT)-based self-assembling prodrug (SAPD) hydrogel that can be used as an adjunct therapy for local treatment of GBM following maximal tumor resection. When dispersed in aqueous solution, the designed CPT prodrug spontaneously assembles into supramolecular filaments with a 100% CPT loading. In both in vitro and ex vivo assays, we show that the designed CPT prodrug can be steadily released from its supramolecular filament hydrogel, effectively killing primary GBM cells derived from patients. We also found that the solution containing self-assembling CPT filaments can be directly applied to the tumor cavity after surgical removal, and forms a gel immediately upon contact with the brain tissue. Our in vivo studies with a resection and recurrence mouse model suggest that this prodrug hydrogel can release cancer therapeutics into brain parenchyma over a long period of time, suppressing tumor recurrence and leading to prolonged survival. We believe that the simplicity in prodrug design and the high efficacy in suppressing GBM growth enable the unique potential of this SAPD hydrogels for clinical translation as an adjunct therapy for GBM treatment. |
WOS关键词 | CONVECTION-ENHANCED DELIVERY ; SUPRAMOLECULAR NANOSTRUCTURES ; SURGICAL RESECTION ; ANTITUMOR-ACTIVITY ; MALIGNANT GLIOMA ; 9L GLIOSARCOMA ; LOCAL-DELIVERY ; BRAIN-TUMORS ; RELEASE ; CAMPTOTHECIN |
资助项目 | National Science Foundation[DMR 1255281] |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:000515538300023 |
出版者 | ELSEVIER |
源URL | [http://119.78.100.183/handle/2S10ELR8/281487] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Quinones-Hinojosa, Alfredo; Cui, Honggang |
作者单位 | 1.Mayo Clin, Dept Neurol Surg, Jacksonville, FL 32224 USA 2.Johns Hopkins Univ, Inst NanoBioTechnol, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA 3.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 5.PECEM UNAM, Plan Combined Studies Med MD PhD Program, Mexico City, DF, Mexico 6.Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA 7.Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA 8.Johns Hopkins Univ, Wilmer Eye Inst, Ctr Nanomed, Sch Med, 400 North Broadway, Baltimore, MD 21231 USA |
推荐引用方式 GB/T 7714 | Schiapparelli, Paula,Zhang, Pengcheng,Lara-Velazquez, Montserrat,et al. Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model[J]. JOURNAL OF CONTROLLED RELEASE,2020,319:311-321. |
APA | Schiapparelli, Paula.,Zhang, Pengcheng.,Lara-Velazquez, Montserrat.,Guerrero-Cazares, Hugo.,Lin, Ran.,...&Cui, Honggang.(2020).Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model.JOURNAL OF CONTROLLED RELEASE,319,311-321. |
MLA | Schiapparelli, Paula,et al."Self-assembling and self-formulating prodrug hydrogelator extends survival in a glioblastoma resection and recurrence model".JOURNAL OF CONTROLLED RELEASE 319(2020):311-321. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。